MedPath
FDA Approval

Betamethasone Dipropionate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
DUNS: 043838424
Effective Date
June 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Betamethasone(0.5 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betamethasone Dipropionate

Product Details

NDC Product Code
0168-0267
Application Number
ANDA077111
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
June 4, 2019
propylene glycolInactive
Code: 6DC9Q167V3Class: IACT
isopropyl alcoholInactive
Code: ND2M416302Class: IACT
Code: 826Y60901UClass: ACTIMQuantity: 0.5 mg in 1 mL
waterInactive
Code: 059QF0KO0RClass: IACT
phosphoric acidInactive
Code: E4GA8884NNClass: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMInactive
Code: 3980JIH2SWClass: IACT
© Copyright 2025. All Rights Reserved by MedPath